8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)
- PMID: 30527953
- DOI: 10.1016/j.jhep.2018.10.032
8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources